Anxuyuan Biotechnology (Shenzhen) Co., Ltd.
PrivateLast Round
Series B
Jun 20, 2022
Est. Valuation
$347.5M
Total Funding Raised
$100M
Company Overview
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. is a biotechnology company that develops semiconductor-based tools for genomic analysis, including nanopore sequencing platforms, Bio-CMOS chip design, and electrochemical sensing for molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Semiconductors, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Comparables
Compare Anxuyuan Biotechnology (Shenzhen) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qitan Tech | 85% | |
| Oxford Nanopore Technologies plc | 78% | |
| Element Biosciences | 74% |
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 20, 2022 | ||||
| Series A Extension | Oct 31, 2021 | ||||
| Angel | Dec 1, 2017 |
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SDIC Fund Management | Series B |
| Widi Capital | Series B |
| Kaitai Capital | Series A Extension |
| MSA Capital | Series A Extension |
| CBC Group | Series B |
| 5Y Capital | Series B, Series A Extension |
| Oriza Hua Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2017
Raised an Angel round with Green Pine Capital Partners.
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s valuation, stock price, and market status.
Is Anxuyuan Biotechnology (Shenzhen) Co., Ltd. a public or private company?
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. is a private company.
What is the current stock price of Anxuyuan Biotechnology (Shenzhen) Co., Ltd.?
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Anxuyuan Biotechnology (Shenzhen) Co., Ltd. worth (valuation)?
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s valuation is estimated at $347.5M based on funding round data.
Can I buy Anxuyuan Biotechnology (Shenzhen) Co., Ltd. stock?
Anxuyuan Biotechnology (Shenzhen) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s last funding round?
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s most recent funding round was Series B on June 20, 2022.
Who are the main investors in Anxuyuan Biotechnology (Shenzhen) Co., Ltd.?
Key investors in Anxuyuan Biotechnology (Shenzhen) Co., Ltd. include Yunfeng Capital.
Will Anxuyuan Biotechnology (Shenzhen) Co., Ltd. IPO soon?
No public IPO plans have been announced for Anxuyuan Biotechnology (Shenzhen) Co., Ltd..
How can I track Anxuyuan Biotechnology (Shenzhen) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s secondary market activity and sign up for updates.